ETC
TNGX icon

Exchange Traded Concepts’s Tango Therapeutics TNGX Stock Holding History

Exchange Traded Concepts’s Portfolio TNGX Stock Details TNGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-65,327
Closed -$89.5K – 1505
2025
Q1 		$89.5K Buy
65,327
+47,901
+275% +$118K ﹤0.01% 1190
2024
Q4 		$53.8K Hold
17,426
– – ﹤0.01% 1219
2024
Q3 		$134K Sell
17,426
-6,483
-27% -$61.9K ﹤0.01% 1100
2024
Q2 		$205K Sell
23,909
-7,437
-24% -$57.5K 0.01% 874
2024
Q1 		$249K Buy
31,346
+14,872
+90% +$159K 0.01% 862
2023
Q4 		$163K Buy
16,474
+4,177
+34% +$36.3K ﹤0.01% 818
2023
Q3 		$138K Sell
12,297
-26,861
-69% -$164K ﹤0.01% 829
2023
Q2 		$130K Buy
+39,158
New +$141K ﹤0.01% 887

Other funds holding TNGX

TGI
TRV GP IV Boston, Massachusetts $267M AUM 965.83% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
BCM
Boxer Capital Management San Diego, California $762M AUM 1,125.36% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
GS
Gilead Sciences Foster City, California $2.12B AUM 143.53% 1-Year Est. Return

Exchange Traded Concepts's TNGX Position: Q2 2025 in Review

Exchange Traded Concepts sold out of Tango Therapeutics (TNGX) in Q2 2025, closing a stake of 65,327 shares — an estimated $89.5K sold.

Exchange Traded Concepts first reported a position in TNGX in Q2 2023 and held it in 8 quarters. The position peaked at $249K in Q1 2024. 115 funds tracked by Wall St. Rank hold TNGX as of Q2 2025.

  • Exchange Traded Concepts reported no remaining Tango Therapeutics position as of Q2 2025 after selling out during the quarter.
  • Exchange Traded Concepts sold 65,327 Tango Therapeutics shares in Q2 2025, an estimated $89.5K.
  • Exchange Traded Concepts first reported a position in Tango Therapeutics in Q2 2023 and held it in 8 quarters.
  • Exchange Traded Concepts's Tango Therapeutics position peaked at $249K in Q1 2024.
  • 115 funds tracked by Wall St. Rank held Tango Therapeutics as of Q2 2025.

Based on Exchange Traded Concepts's 13F filing for Q2 2025, filed 10 Jul 2025.